Healthcare Referral Fees and Marketing Agency Contracts: NMC 2026

Why ordinary marketing terms may mislead

Performance marketers measure cost per lead, appointment and conversion. Professional medicine is different: a patient is not a conventional commercial referral unit. The 2026 guidelines address direct/indirect solicitation, prohibited commissions and agency or influencer remuneration connected with procuring patients. S1

A fee structure that makes commercial compensation depend on an individual patient being delivered for treatment merits special scrutiny even if the payer describes it as technology or campaign optimisation.

Clause 8.1(vii): the nature of prohibited consideration

The text bars an RMP from directly or indirectly offering, paying, soliciting, receiving or participating in commissions, rebates, bonuses, gifts, gratuities, referral fees, lead-generation fees or other consideration linked to procurement, recommendation or referral of patients, specimens or other materials for medical services. S1

Examine both sides of the transaction. A paid intermediary, a prescribing doctor, a referral broker and an agency may not all be subject to identical disciplinary jurisdiction, but the commercial relationship can be relevant evidence.

Clause 8.1(viii): agency contracts

The notice specifically addresses engagements of digital agencies, marketing agencies, influencers and online platforms where payment is linked to procurement or referral of individual patients. It does not say every fixed-price design, web-development or administrative arrangement is approved.

A hospital retains an agency for website accessibility, updating verified facilities and managing a lawful information library. That service scope differs from an arrangement where remuneration rises for every named surgery patient sent to the hospital. The actual conduct, not only contract terminology, matters.

Example: three hypothetical arrangements

Creative production fixed fee: A provider is paid for designing medically reviewed illustrations without patient solicitation. This is potentially more defensible on fee mechanics, though underlying content requires review.

Monthly campaign retainer: A fixed monthly amount is charged for advertising management. Not automatically compliant; the campaigns may still amount to prohibited solicitation.

Per-procedure patient fee: A third party receives money for each booked or completed procedure. This is directly within the procurement concern and should be escalated.

Referral arrangements are not uniform across healthcare

Insurance TPAs, provider directories, hospital vendors and clinical referral pathways serve different functions. A genuine medical referral made for patient benefit is not automatically the same as a fee-for-patient transaction. Evidence should address whether money, inducement or concealed interests affected professional independence.

What the compliance review should inspect

Read the statement of work, lead definitions, invoices, payment triggers, CRM attribution rules, referral codes, WhatsApp scripts, financial arrangements with RMPs, influencer briefs, external booking widgets and ownership of patient data. Preserve historical versions rather than retroactively rewriting records.

Contract drafting safeguards

Specify factual and educational deliverables, prohibit patient-linked procurement fees and fabricated claims, assign clinical-approval responsibilities, restrict patient-data reuse, require audit cooperation and establish a complaints/correction procedure. Indemnity wording may allocate private risk but cannot simply contract out statutory responsibility.

A commercially realistic alternative

Measure accessible information quality, factual corrections, content delivery, website performance and operational responsiveness rather than treating each patient as a payable acquisition unit. Such measures still require the institution to ensure the underlying marketing activity is permitted.